Boxer Capital’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Boxer Capital’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-488,157	Closed	-$382K	–	76
2022 Q3	$382K	Sell	488,157 -361,908	-43%	-$760K	0.02%	69
2022 Q2	$2.45M	Hold	850,065	–	–	0.16%	64
2022 Q1	$5.33M	Hold	850,065	–	–	0.27%	54
2021 Q4	$9.47M	Sell	850,065 -180,000	-17%	-$2.5M	0.37%	47
2021 Q3	$16.8M	Hold	1,030,065	–	–	0.59%	49
2021 Q2	$19.1M	Hold	1,030,065	–	–	0.67%	47
2021 Q1	$15.5M	Buy	1,030,065 +427,415	+71%	+$9.29M	0.53%	52
2020 Q4	$19.5M	Buy	+602,650	New	+$7.97M	0.63%	45

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Boxer Capital's CDAK Position: Q4 2022 in Review

Boxer Capital sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q4 2022, closing a stake of 488,157 shares — an estimated $382K sold.

Boxer Capital first reported a position in CDAK in Q4 2020 and held it in 8 quarters. The position peaked at $19.5M in Q4 2020. 40 funds tracked by Wall St. Rank hold CDAK as of Q4 2022.

Boxer Capital reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Boxer Capital sold 488,157 Codiak BioSciences, Inc. Common Stock shares in Q4 2022, an estimated $382K.
Boxer Capital first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Boxer Capital's Codiak BioSciences, Inc. Common Stock position peaked at $19.5M in Q4 2020.
40 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q4 2022.

Based on Boxer Capital's 13F filing for Q4 2022, filed 14 Feb 2023.